PlanA
Core trisomies
Trisomies 13, 18 and 21
176,000円tax included
160,000円（税抜）NIPT TESTS & PRICING
Tests and pricing
Compare the four currently listed plans by scope, price and limitations.
Short answer
All plans include screening for trisomies 13, 18 and 21. Plans B, C and D add different combinations of sex chromosomes, fetal sex, whole-chromosome analysis, SMA, fragile X syndrome and selected microdeletions.
PlanB
Whole-chromosome
Core trisomies + sex chromosomes + fetal sex + whole-chromosome analysis
220,000円tax included
200,000円（税抜）PlanC
Whole-chromosome + inherited conditions
Plan B + SMA + fragile X syndrome
253,000円tax included
230,000円（税抜）PlanD
Whole-chromosome + microdeletions
Core trisomies + whole-chromosome analysis + fetal sex + selected microdeletions
253,000円tax included
230,000円（税抜）| Test item | Plan A | Plan B | Plan C | Plan D |
|---|---|---|---|---|
| Trisomies 13, 18 and 21 | ●Included | ●Included | ●Included | ●Included |
| Sex chromosome analysis | —Not included | ●Included | ●Included | —Not included |
| Fetal sex | —Not included | ●Included | ●Included | ●Included |
| Whole-chromosome analysis | —Not included | ●Included | ●Included | ●Included |
| Spinal muscular atrophy (SMA) | —Not included | —Not included | ●Included | —Not included |
| Fragile X syndrome | —Not included | —Not included | ●Included | —Not included |
| Selected microdeletions | —Not included | —Not included | —Not included | ●Included |
TEST SCOPE
Understand each part of the scope
Each plan separates the conditions screened from information outside its scope.
Core trisomies
Estimates the chance of trisomy 13 (Patau syndrome), trisomy 18 (Edwards syndrome) and trisomy 21 (Down syndrome).
Sex chromosomes
Screens for selected numerical sex-chromosome differences, including patterns associated with Turner, Klinefelter and triple X syndromes.
Whole-chromosome analysis
Analyses numerical differences across autosomes 1–22 and sex chromosomes. The meaning of a result varies by chromosome.
Selected microdeletions
Selected regions are explained according to the plan. Refer to the pre-test information for the current scope.
SMA, fragile X and DMD
These differ from NIPT in purpose, specimen and interpretation. Confirm genes, method, price and eligibility separately.
Outside test scope
NIPT does not assess every congenital condition, structural difference, developmental outcome or future health state.
PROCESS
From consultation to result
- 01
Initial consultation
Confirm gestational age, pregnancy details, preferred area, clinic or home-visit preference, and test scope.
- 02
Consultation, consent and blood draw
Visit a partner provider, or use nurse home collection when a participating provider can arrange it, then provide about 10 ml of blood after the required consultation and consent.
- 03
Shipping and analysis
The specimen is sent to an overseas laboratory for the selected analysis.
- 04
Result
The current estimate is 10–14 days after laboratory receipt.
LIMITATIONS
Compare scope and limitations—not price alone
- NIPT is screening, not diagnosis, and does not assess every congenital condition.
- A positive or inconclusive result should be discussed with a medical provider.
- Test items and service conditions vary by plan. Review the pre-test information before applying.
- Consultation, blood collection, diagnostic testing or repeat sampling may involve separate charges.
FAQ
Frequently asked questions
Are there costs beyond the listed price?
Consultation, blood collection, diagnostic testing or repeat sampling may involve separate charges. Confirm the total when booking.
How do the plans differ?
The plans differ in whether they include sex chromosomes, whole-chromosome analysis, selected inherited conditions or selected microdeletions.
SOURCES
Sources and references
CONSULTATION
Not sure which plan fits your needs?
We can review scope, price and eligibility with you.